|
Trump, who takes office on Jan. 20, is scheduled to speak in New
York at 11:00 a.m. ET.
Trump's election in November sparked a record-setting rally, but
investors now want evidence on whether he keeps his
campaign-trail promises to stimulate the economy through
increased public spending, tax cuts and the repatriation of U.S.
companies' funds from overseas.
The dollar <.DXY>, which has also basked in Trump's victory, was
up against the yen. However, concerns of some of his
protectionist statements have kept investors wary.
Keeping futures afloat were oil prices, which edged up for the
first time in three days after Saudi Arabia provided details of
a February supply cut to some of its Asian customers. [O/R]
Investors are also closely watching the upcoming corporate
earnings season, which kicks off with big banks on Friday, to
see if financial results can support the lofty valuations Wall
Street is trading at.
The combined profit of S&P 500 companies is estimated to have
risen 5.8 percent in the fourth quarter - the best in three
years - largely helped by financials stocks, according to
Thomson Reuters I/B/E/S.
New York Federal Reserve President William Dudley is expected to
speak on banking regulations at 01:20 p.m. ET.
Among stocks, Merck <MRK.N> rose 1.85 percent to $61.03
premarket after the FDA agreed to a speedy review of the
company's application to combine immunotherapy with other drugs
to treat lung cancer.
AstraZeneca <AZN.N> and Bristol-Myers <BMY.N>, which are also
developing similar therapies, were down 1.5 percent and 3.3
percent, respectively.
Archer Daniels <ADM.N> fell 5.6 percent to $41.96 after China
increased punitive tariffs on U.S. imports of an animal feed
which would affect the global ethanol trader.
(Reporting by Yashaswini Swamynathan in Bengaluru; Editing by
Savio D'Souza)
[© 2017 Thomson Reuters. All rights
reserved.] Copyright 2017 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
 |
|
